Neuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A Review
Top Cited Papers
- 1 June 2000
- journal article
- review article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 157 (6), 867-876
- https://doi.org/10.1176/appi.ajp.157.6.867
Abstract
Neuropsychiatric symptoms are commonly associated with chronic hepatitis C virus infection, its sequelae, and its treatment. In particular, interferon, a primary component of treatment for chronic hepatitis C, has been strongly associated with depressive symptoms. This review summarizes current knowledge about the etiology, course, and treatment of neuropsychiatric problems associated with hepatitis C and interferon alpha (IFN-alpha) treatment. Studies were identified by computerized searches, and further references were obtained from bibliographies of the reviewed articles. Chronic infection with the hepatitis C virus is a common and growing problem, often affecting persons with psychiatric and substance use problems. Although changes in cognition, mood, and personality have been described in association with hepatitis C and with IFN-alpha treatment, there has been little systematic study of these changes. Psychiatrists should become familiar with the clinical spectrum associated with hepatitis C virus infection as well as the neuropsychiatric symptoms related to hepatitis C and IFN-alpha treatment. More studies are necessary to define the neuropsychiatric syndromes associated with this population and to find possible effective treatments. Furthermore, research is needed so that patients with psychiatric problems are not excluded from effective treatments for this growing medical problem.Keywords
This publication has 80 references indexed in Scilit:
- Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosisCancer, 1998
- Neurotoxicity of interferon-? in melanoma therapyCancer, 1998
- Treatment of Depression Improves Adherence to Interferon Beta-1b Therapy for Multiple SclerosisArchives of Neurology, 1997
- Mood-Lowering Effect of Tryptophan DepletionArchives of General Psychiatry, 1994
- Adrenal Gland Enlargement in Major DepressionArchives of General Psychiatry, 1992
- Serotonin Function and the Mechanism of Antidepressant ActionArchives of General Psychiatry, 1990
- Psychiatric complications of long-term interferon alfa therapyArchives of Internal Medicine, 1987
- Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancerPublished by American Medical Association (AMA) ,1984
- A Self-Rating Depression ScaleArchives of General Psychiatry, 1965
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961